All Stories

  1. Quizartinib with donor lymphocyte infusion for post-transplant relapse of FLT3-ITD-positive acute myeloid leukemia

    Article • International Journal of Hematology, October 2024, Springer Science + Business Media

    Dr Yuho Najima

  2. Lower-dose post-transplant cyclophosphamide in haploidentical hematopoietic cell transplantation

    Article • Bone Marrow Transplantation, August 2024, Springer Science + Business Media

    Dr Yuho Najima

  3. Overcoming post‐transplant graft failure and adenovirus infection in a patient with FLT3‐TKD‐mutated mixed‐phenotype acute leukemia: A case report

    Article • eJHaem, June 2024, Wiley

    Dr Yuho Najima

  4. Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies

    Article • Bone Marrow Transplantation, May 2024, Springer Science + Business Media

    Dr Yuho Najima

  5. Outcomes of Cessation of Nucleos(t)ide Analog Administration on Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective Study

    Article • Transplantation and Cellular Therapy, March 2024, Elsevier

    Dr Yuho Najima

  6. Recurrent DDX41 mutation in very late relapse after allogeneic stem cell transplantation

    Article • Leukemia, January 2024, Springer Science + Business Media

    Dr Yuho Najima

  7. Low‐ versus standard‐dose post‐transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation

    Article • British Journal of Haematology, November 2023, Wiley

    Dr Yuho Najima

  8. Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies

    Article • November 2023, Research Square

    Dr Yuho Najima

  9. Overcoming relapse: prophylactic or pre-emptive use of azacitidine or FLT3 inhibitors after allogeneic transplantation for AML or MDS

    Article • International Journal of Hematology, April 2023, Springer Science + Business Media

    Dr Yuho Najima

  10. Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia

    Article • Cancer Science, January 2023, Wiley

    Dr Yuho Najima

  11. A third dose of COVID‐19 mRNA vaccine induces limited humoral response in stem cell transplant recipients who got two vaccine doses before transplant

    Article • eJHaem, December 2022, Wiley

    Dr Yuho Najima

  12. Central nervous system mucormycosis in a patient with hematological malignancy: A case report and review of the literature

    Article • Journal of Infection and Chemotherapy, December 2022, Elsevier

    Dr Yuho Najima

  13. Phase I trial of myeloablative conditioning with three‐day total marrow and lymphoid irradiation for leukemia

    Article • Cancer Science, October 2022, Wiley

    Dr Yuho Najima

  14. Dose-finding trial of azacitidine as post-transplant maintenance for high-risk MDS: a KSGCT prospective study

    Article • Annals of Hematology, September 2022, Springer Science + Business Media

    Dr Yuho Najima

  15. Antithymocyte Globulin Potentially Could Overcome an Adverse Effect of Acute Graft-versus-Host Disease in Matched-Related Peripheral Blood Stem Cell Transplantation

    Article • Transplantation and Cellular Therapy, March 2022, Elsevier

    Dr Yuho Najima

  16. Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia

    Article • Blood Advances, January 2022, American Society of Hematology

    Dr Yuho Najima

  17. Paraplegia via hematogenous dissemination of Cunninghamella elegans (mucormycosis) after hematopoietic stem cell transplantation

    Article • International Journal of Infectious Diseases, December 2021, Elsevier

    Dr Yuho Najima

  18. Retrospective comparison of hematopoietic stem cell transplantation following reduced-intensity conditioning with fludarabine/low-dose melphalan plus 4 Gy TBI versus fludarabine/ busulfan plus 4 Gy TBI

    Article • International Journal of Hematology, October 2021, Springer Science + Business Media

    Dr Yuho Najima

  19. Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis

    Article • Bone Marrow Transplantation, September 2021, Springer Science + Business Media

    Dr Yuho Najima

  20. Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study

    Article • Leukemia Research, September 2021, Elsevier

    Dr Yuho Najima

  21. Prognostic factors in salvage transplantation for graft failure following allogeneic hematopoietic stem cell transplantation

    Article • Bone Marrow Transplantation, April 2021, Springer Science + Business Media

    Dr Yuho Najima

  22. A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin

    Article • Annals of Hematology, January 2021, Springer Science + Business Media

    Dr Yuho Najima

  23. Successful Cord Blood Transplantation for Idiopathic CD4<sup>+</sup> Lymphocytopenia

    Article • Acta Haematologica, January 2021, Karger Publishers

    Dr Yuho Najima

  24. Clinical Benefits of Preconditioning Intervention in Patients with Relapsed or Refractory Acute Myelogenous Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A Kanto Study of Group for Cell Therapy Multicenter Analysis

    Article • Transplantation and Cellular Therapy, January 2021, Elsevier

    Dr Yuho Najima

  25. T-cell receptor repertoire of cytomegalovirus-specific cytotoxic T-cells after allogeneic stem cell transplantation

    Article • Scientific Reports, December 2020, Springer Science + Business Media

    Dr Yuho Najima

  26. Intraventricular rupture of Aspergillus brain abscess during remission induction

    Article • International Journal of Infectious Diseases, December 2020, Elsevier

    Dr Yuho Najima

  27. Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation

    Article • Blood Advances, September 2020, American Society of Hematology

    Dr Yuho Najima

  28. Safety of total body irradiation using intensity-modulated radiation therapy by helical tomotherapy in allogeneic hematopoietic stem cell transplantation: a prospective pilot study

    Article • Journal of Radiation Research, September 2020, Oxford University Press (OUP)

    Dr Yuho Najima

  29. Use of unapproved or off-label drugs in Japan for the treatment of graft-versus-host disease and post-transplant viral infection

    Article • International Journal of Hematology, September 2020, Springer Science + Business Media

    Dr Yuho Najima

  30. The impacts of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation

    Article • Annals of Hematology, August 2020, Springer Science + Business Media

    Dr Yuho Najima

  31. Prognostic impact of TP53 mutation, monosomal karyotype, and prior myeloid disorder in nonremission acute myeloid leukemia at allo-HSCT

    Article • Bone Marrow Transplantation, August 2020, Springer Science + Business Media

    Dr Yuho Najima

  32. Nontuberculous mycobacterial bloodstream infections after allogeneic hematopoietic stem cell transplantation

    Article • International Journal of Infectious Diseases, August 2020, Elsevier

    Dr Yuho Najima

  33. Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation

    Article • Annals of Hematology, June 2020, Springer Science + Business Media

    Dr Yuho Najima

  34. Bone turnover markers as an aid to monitor osteoporosis following allogeneic hematopoietic stem cell transplantation

    Article • Annals of Hematology, May 2020, Springer Science + Business Media

    Dr Yuho Najima

  35. Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemi...

    Article • Bone Marrow Transplantation, May 2020, Springer Science + Business Media

    Dr Yuho Najima

  36. Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia conducted in Japan during the past quarter century

    Article • Annals of Hematology, May 2020, Springer Science + Business Media

    Dr Yuho Najima

  37. Outcomes and Prognostic Factors for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A KSGCT Multicenter Analysis

    Article • Biology of Blood and Marrow Transplantation, May 2020, Elsevier

    Dr Yuho Najima

  38. Late appearance of eosinophilia in myeloid blast phase of myeloid neoplasm with rearrangement of PDGFRβ

    Article • Leukemia & Lymphoma, February 2020, Taylor & Francis

    Dr Yuho Najima

  39. Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia harboring t(1;19)(q23;p13.3); comparison with normal karyotype

    Article • Bone Marrow Transplantation, February 2020, Springer Science + Business Media

    Dr Yuho Najima

  40. The sensitivity of the FLT3-ITD detection method is an important consideration when diagnosing acute myeloid leukemia

    Article • Leukemia Research Reports, January 2020, Elsevier

    Dr Yuho Najima

  41. Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre‐transplant conditioning using fludarabine, reduced‐dose cyclophosphamide, and low‐dose thymoglobulin: A KSGCT prospective study

    Article • American Journal of Hematology, December 2019, Wiley

    Dr Yuho Najima

  42. The emergence of rare nocardiosis following allogeneic hematopoietic stem cell transplantation in the era of molecular taxonomy

    Article • International Journal of Infectious Diseases, December 2019, Elsevier

    Dr Yuho Najima

  43. Unmanipulated haploidentical hematopoietic stem cell transplantation using very low-dose antithymocyte globulin and methylprednisolone in adults with relapsed/refractory acute leukemia

    Article • Annals of Hematology, November 2019, Springer Science + Business Media

    Dr Yuho Najima

  44. A case of polycythemia vera diagnosed after postextraction hemorrhage

    Article • Japanese Journal of Oral & Maxillofacial Surgery, September 2019, Japanese Society of Oral and Maxillofacial Surgeons

    Dr Yuho Najima

  45. Allogeneic hematopoietic cell transplantation in patients with untreated acute myeloid leukemia: a KSGCT multicenter retrospective analysis

    Article • Bone Marrow Transplantation, September 2019, Springer Science + Business Media

    Dr Yuho Najima

  46. Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemia

    Article • International Journal of Hematology, August 2019, Springer Science + Business Media

    Dr Yuho Najima

  47. The Authors' Reply to "The Addition of Prophylactic Antibiotics Can Achieve a Favorable Outcome"

    Article • Internal Medicine, August 2019, Japanese Society of Internal Medicine

    Dr Yuho Najima

  48. Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis

    Article • Leukemia, May 2019, Springer Science + Business Media

    Dr Yuho Najima

  49. Nutritional risk index as a risk factor for breakthrough candidemia in allogeneic hematopoietic stem cell transplantation

    Article • Bone Marrow Transplantation, May 2019, Springer Science + Business Media

    Dr Yuho Najima

  50. Disseminated adenovirus infection in a patient with relapsed refractory multiple myeloma undergoing autologous stem cell transplantation and pomalidomide/dexamethasone as salvage regimens

    Article • Journal of Infection and Chemotherapy, May 2019, Elsevier

    Dr Yuho Najima

  51. Successful hematopoietic stem-cell mobilization with plerixafor plus granulocyte-colony stimulating factor in multiple myeloma patients treated with pomalidomide

    Article • International Journal of Hematology, April 2019, Springer Science + Business Media

    Dr Yuho Najima

  52. Geriatric nutritional risk index (GNRI) just before allogeneic hematopoietic stem cell transplantation predicts transplant outcomes in patients older than 50 years with acute myeloid leukemia in complete remission

    Article • Annals of Hematology, March 2019, Springer Science + Business Media

    Dr Yuho Najima

  53. Co-activation of macrophages and T cells contribute to chronic GVHD in human IL-6 transgenic humanised mouse model

    Article • EBioMedicine, March 2019, Elsevier

    Dr Yuho Najima

  54. Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial

    Article • Acta Haematologica, January 2019, Karger Publishers

    Dr Yuho Najima

  55. Fatal Neutropenic Enterocolitis Caused by <i>Stenotrophomonas maltophilia</i>: A Rare and Underrecognized Entity

    Article • Internal Medicine, December 2018, Japanese Society of Internal Medicine

    Dr Yuho Najima

  56. Reassessment of clinical implication of pretransplant surgical procedures for pulmonary invasive fungal lesions

    Article • Transplant Infectious Disease, November 2018, Wiley

    Dr Yuho Najima

  57. Clinical Efficacy of Prebiotics on Transplant-Related Complications

    Article • Blood, November 2018, American Society of Hematology

    Dr Yuho Najima

  58. Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia

    Article • Blood Advances, October 2018, American Society of Hematology

    Dr Yuho Najima

  59. Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

    Article • Annals of Hematology, July 2018, Springer Science + Business Media

    Dr Yuho Najima

  60. Deregulated Mucosal Immune Surveillance through Gut-Associated Regulatory T Cells and PD-1+ T Cells in Human Colorectal Cancer

    Article • The Journal of Immunology, May 2018, The American Association of Immunologists

    Dr Yuho Najima

  61. Outcome of patients with acute undifferentiated leukemia after allogeneic hematopoietic stem cell transplantation

    Article • Leukemia & Lymphoma, April 2018, Taylor & Francis

    Dr Yuho Najima

  62. Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia

    Article • Biology of Blood and Marrow Transplantation, April 2018, Elsevier

    Dr Yuho Najima

  63. Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response—The final results of the D-first study

    Article • Leukemia Research, March 2018, Elsevier

    Dr Yuho Najima

  64. A prospective multicenter phase II study of intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning

    Article • European Journal Of Haematology, January 2018, Wiley

    Dr Yuho Najima

  65. Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302)

    Article • International Journal of Hematology, January 2018, Springer Science + Business Media

    Dr Yuho Najima

  66. Outcomes after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia harboring t(7;11)(p15;p15)

    Article • Haematologica, November 2017, Ferrata Storti Foundation (Haematologica)

    Dr Yuho Najima

  67. Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation

    Article • BMC Infectious Diseases, September 2017, Springer Science + Business Media

    Dr Yuho Najima

  68. Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation

    Article • Annals of Hematology, July 2017, Springer Science + Business Media

    Dr Yuho Najima, Yutaka Shimazu

  69. Diagnostic open brain biopsy following initial negative results of cerebrospinal fluid assessment forToxoplasma

    Article • Transplant Infectious Disease, March 2017, Wiley

    Dr Yuho Najima

  70. Central nervous system infection following allogeneic hematopoietic stem cell transplantation

    Article • Hematology/Oncology and Stem Cell Therapy, March 2017, King Faisal Specialist Hospital and Research Centre - DIGITAL COMMONS JOURNALS

    Dr Yuho Najima

  71. Erythrocytosis after allogeneic hematopoietic stem cell transplantation

    Article • Clinical Transplantation, February 2017, Wiley

    Dr Yuho Najima

  72. Impact of Human Leukocyte Antigen Allele Mismatch in Unrelated Bone Marrow Transplantation with Reduced-Intensity Conditioning Regimen

    Article • Biology of Blood and Marrow Transplantation, February 2017, Elsevier

    Dr Yuho Najima

  73. Extramedullary Gastric Relapse at the Time of Bone Marrow Relapse of Acute Lymphoblastic Leukemia after Allogeneic Bone Marrow Transplantation

    Article • Internal Medicine, January 2017, Japanese Society of Internal Medicine

    Dr Yuho Najima

  74. Mesenchymal Stem Cells: The First Approved Stem Cell Drug in Japan

    Article • Journal of Hematopoietic Cell Transplantation, January 2017, The Japan Society for Hematopoietic Stem Cell Transplantation

    Dr Yuho Najima

  75. Central Nervous System Involvement at the Time of Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with a Poor Outcome in Patients with Acute Myeloid Leukemia

    Article • Pathology & Oncology Research, December 2016, Springer Science + Business Media

    Dr Yuho Najima

  76. the Safety and Efficacy of Deferasirox for the Transplant Patients with Iron Overload

    Article • Blood, December 2016, American Society of Hematology

    Dr Yuho Najima

  77. Clinical Impact of Pre-Transplant Microbial Diversity on Transplant Outcomes

    Article • Blood, December 2016, American Society of Hematology

    Dr Yuho Najima

  78. Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

    Article • Annals of Hematology, October 2016, Springer Science + Business Media

    Dr Yuho Najima

  79. Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut

    Article • Blood, October 2016, American Society of Hematology

    Dr Yuho Najima

  80. Comparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantation

    Article • International Journal of Hematology, August 2016, Springer Science + Business Media

    Dr Yuho Najima

  81. Clinical utility of high-flow nasal cannula oxygen therapy for acute respiratory failure in patients with hematological disease

    Article • SpringerPlus, April 2016, Springer Science + Business Media

    Dr Yuho Najima

  82. Induction of WT1-specific human CD8+ T cells from human HSCs in HLA class I Tg NOD/SCID/IL2rgKO mice

    Article • Blood, February 2016, American Society of Hematology

    Dr Yuho Najima

  83. Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study

    Article • Leukemia Research, February 2016, Elsevier

    Dr Yuho Najima

  84. Comparison of Outcomes of 8/8 and 7/8 Allele–Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia

    Article • Biology of Blood and Marrow Transplantation, February 2016, Elsevier

    Dr Yuho Najima

  85. Allogeneic hematopoietic stem cell transplant overcomes poor prognosis of acute myeloid leukemia with myelodysplasia-related changes

    Article • Leukemia & Lymphoma, January 2016, Taylor & Francis

    Dr Yuho Najima

  86. Severe Hypoxemia in a Healthy Donor for Allogeneic Hematopoietic Stem Cell Transplantation after Only the First Administration of Granulocyte-Colony Stimulating Factor

    Article • Transfusion Medicine and Hemotherapy, January 2016, Karger Publishers

    Dr Yuho Najima

  87. Occurrence of Donor Cell-derived Lymphoid Blast Crisis 24 Years Following Related Bone Marrow Transplantation for Chronic Myeloid Leukemia

    Article • Internal Medicine, January 2016, Japanese Society of Internal Medicine

    Dr Yuho Najima

  88. CD25 expression on residual leukemic blasts at the time of allogeneic hematopoietic stem cell transplant predicts relapse in patients with acute myeloid leukemia without complete remission

    Article • Leukemia & Lymphoma, December 2015, Taylor & Francis

    Dr Yuho Najima

  89. Clinical impact of hematogones on outcomes of allogeneic hematopoietic stem cell transplantation

    Article • Annals of Hematology, September 2015, Springer Science + Business Media

    Dr Yuho Najima

  90. Early-onset acute kidney injury is a poor prognostic sign for allogeneic SCT recipients

    Article • Bone Marrow Transplantation, August 2015, Springer Science + Business Media

    Dr Yuho Najima

  91. Dasatinib-induced gastric antral vascular ectasia in a patient with acute lymphoblastic leukaemia

    Article • British Journal of Haematology, April 2015, Wiley

    Dr Yuho Najima

  92. The Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Elderly Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) in the Era of Tyrosine Kinase Inhibitor (TKI) : A Single Institute Experience

    Article • Biology of Blood and Marrow Transplantation, February 2015, Elsevier

    Dr Yuho Najima

  93. Post-transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high-risk acute myeloid leukaemia

    Article • British Journal of Haematology, December 2014, Wiley

    Dr Yuho Najima

  94. Urinary Liver-Type Fatty Acid-Binding Protein Linked with Increased Risk of Acute Kidney Injury after Allogeneic Stem Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, December 2014, Elsevier

    Dr Yuho Najima

  95. Toxic encephalopathy after exposure to azacitidine

    Article • Leukemia & Lymphoma, November 2014, Taylor & Francis

    Dr Yuho Najima

  96. Contribution of Bone Marrow-Derived Hematopoietic Stem/Progenitor Cells to the Generation of Donor-Marker+ Cardiomyocytes In Vivo

    Article • PLoS ONE, May 2013, PLOS

    Dr Yuho Najima

  97. A Pyrrolo-Pyrimidine Derivative Targets Human Primary AML Stem Cells in Vivo

    Article • Science Translational Medicine, April 2013, American Association for the Advancement of Science

    Dr Yuho Najima

  98. Il2rg Gene-Targeted Severe Combined Immunodeficiency Pigs

    Article • Cell Stem Cell, June 2012, Elsevier

    Dr Yuho Najima, Dr Tony Perry

  99. Incidence, risk factors, and clinical outcomes of cataracts following hematopoietic stem cell transplantation

    Article • American Journal of Hematology, April 2011, Wiley

    Dr Yuho Najima

  100. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnullhumanized mice

    Article • Proceedings of the National Academy of Sciences, July 2010, Proceedings of the National Academy of Sciences

    Dr Yuho Najima

  101. Molecular monitoring of BAALC expression in patients with CD34-positive acute leukemia

    Article • International Journal of Hematology, April 2010, Springer Science + Business Media

    Dr Yuho Najima

  102. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML

    Article • Nature Biotechnology, February 2010, Springer Science + Business Media

    Dr Yuho Najima

  103. Identification of Therapeutic Targets for Quiescent, Chemotherapy-Resistant Human Leukemia Stem Cells

    Article • Science Translational Medicine, February 2010, American Association for the Advancement of Science

    Dr Yuho Najima

  104. Cell Cycle Entry Potentiates Elimination of Chemotherapy-Resistant Human AML Stem Cells.

    Article • Blood, November 2009, American Society of Hematology

    Dr Yuho Najima

  105. Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation

    Article • American Journal of Hematology, May 2009, Wiley

    Dr Yuho Najima

  106. Quantitative Monitoring of T315I BCR-ABL Mutation by the Invader Assay.

    Article • Blood, November 2007, American Society of Hematology

    Dr Yuho Najima

  107. Molecular Monitoring of ERG and BAALC as Minimal Residual Disease Markers in Patients with Acute Leukemia.

    Article • Blood, November 2007, American Society of Hematology

    Dr Yuho Najima

  108. Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma

    Article • European Journal of Cancer, June 2005, Elsevier

    Dr Yuho Najima

  109. High Mobility Group Protein-B1 Interacts with Sterol Regulatory Element-binding Proteins to Enhance Their DNA Binding

    Article • Journal of Biological Chemistry, May 2005, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Yuho Najima

  110. p53 Involvement in the Pathogenesis of Fatty Liver Disease

    Article • Journal of Biological Chemistry, February 2004, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Yuho Najima

  111. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression

    Article • Hepatology, December 2003, Wiley

    Dr Yuho Najima

  112. p53 Activation in Adipocytes of Obese Mice

    Article • Journal of Biological Chemistry, May 2003, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Yuho Najima